Alzheimer's Disease: Rethinking Things?
A very readable piece from Gina Kolata of the New York Times:
Doubt on Tactic in Alzheimer’s Battle
By GINA KOLATA
The New York Times
Published: August 18, 2010
"The failure of a promising Alzheimer’s drug highlights the gap between diagnosis and treatment."
Read the full article
Doubt on Tactic in Alzheimer’s Battle
By GINA KOLATA
The New York Times
Published: August 18, 2010
"The failure of a promising Alzheimer’s drug highlights the gap between diagnosis and treatment."
Read the full article
Labels: Alzheimer, brain, clinical trials, CNS, dementia, neurodegenerative, neuropsychology, neuroscience, pharma, pharmaceutical companies
posted by Anthony Risser at 6:40 PM
1 Comments:
What if the accumulation of plaques is a response to some other mechanism which has more to do with the disease progression? It seems as though the entire pathway needs another look.
Post a Comment
<< Home